Adaptation of New Oral Anticoagulants for Warfarin Anticoagulated Patient with Traumatic Ongoing Hemorrhage
Journal of Acute Care Surgery
;
(2): 33-37, 2018.
Article
in Korean
| WPRIM
| ID: wpr-714317
ABSTRACT
The traditional drug for anticoagulation in those with a high risk of thrombosis is a vitamin K antagonist, such as warfarin. On the other hand, this drug has several limitations and hemorrhagic complications. Recently, novel or non-vitamin K-dependent antagonist oral anticoagulants (NOACs) have been developed to solve these problems. This paper presents a case of adaptation of NOAC for a warfarin anticoagulated patient with traumatic ongoing hemorrhages with a discussion of the clinical implications of NOAC.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Thrombosis
/
Vitamin K
/
Warfarin
/
Hand
/
Hemorrhage
/
Anticoagulants
Limits:
Humans
Language:
Korean
Journal:
Journal of Acute Care Surgery
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS